Genetically engineered T cells to target EGFRvIII expressing glioblastoma

類似資料

• Development of third generation anti-EGFRvIII chimeric T cells and EGFRvIII-expressing artificial antigen presenting cells for adoptive cell therapy for glioma.
  著者:: Ayguen Sahin, 等
  出版事項: (2018-01-01)
• Development of third generation anti-EGFRvIII chimeric T cells and EGFRvIII-expressing artificial antigen presenting cells for adoptive cell therapy for glioma
  著者:: Sahin, Ayguen, 等
  出版事項: (2018)
• Efficacy of osimertinib against EGFRvIII+ glioblastoma
  著者:: Chagoya, Gustavo, 等
  出版事項: (2020)
• EGFRvIII and c-Met pathway inhibitors synergize against PTEN-null/EGFRvIII(+) glioblastoma xenografts
  著者:: Lal, Bachchu, 等
  出版事項: (2009)
• Mapping of genomic EGFRvIII deletions in glioblastoma: insight into rearrangement mechanisms and biomarker development
  著者:: Koga, Tomoyuki, 等
  出版事項: (2018)